| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6117020 | Immunology Letters | 2015 | 26 Pages |
Abstract
In this review, we will discuss the biologic rationale that makes MSCs a promising therapeutic tool for IBD, and analyze recent experimental and clinical findings, highlighting current limitations and future perspectives of MSCs-related immunotherapy for IBD.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
M. Algeri, A. Conforti, A. Pitisci, N. Starc, L. Tomao, M.E. Bernardo, F. Locatelli,